• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于基因本体论(GO)的肌肉萎缩相关候选蛋白质标志物的推断。

Gene Ontology (GO)-Driven Inference of Candidate Proteomic Markers Associated with Muscle Atrophy Conditions.

机构信息

Centre for Health Science, Division of Biomedical Sciences, Institute of Health Research and Innovation, School of Health, Social Care and Life Sciences, University of the Highlands and Islands, Inverness IV2 3JH, UK.

Edinburgh Cancer Research UK Tissue Group, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh EH4 2XR, UK.

出版信息

Molecules. 2022 Aug 27;27(17):5514. doi: 10.3390/molecules27175514.

DOI:10.3390/molecules27175514
PMID:36080280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9457532/
Abstract

Skeletal muscle homeostasis is essential for the maintenance of a healthy and active lifestyle. Imbalance in muscle homeostasis has significant consequences such as atrophy, loss of muscle mass, and progressive loss of functions. Aging-related muscle wasting, sarcopenia, and atrophy as a consequence of disease, such as cachexia, reduce the quality of life, increase morbidity and result in an overall poor prognosis. Investigating the muscle proteome related to muscle atrophy diseases has a great potential for diagnostic medicine to identify (i) potential protein biomarkers, and (ii) biological processes and functions common or unique to muscle wasting, cachexia, sarcopenia, and aging alone. We conducted a meta-analysis using gene ontology (GO) analysis of 24 human proteomic studies using tissue samples (skeletal muscle and adipose biopsies) and/or biofluids (serum, plasma, urine). Whilst there were few similarities in protein directionality across studies, biological processes common to conditions were identified. Here we demonstrate that the GO analysis of published human proteomics data can identify processes not revealed by single studies. We recommend the integration of proteomics data from tissue samples and biofluids to yield a comprehensive overview of the human skeletal muscle proteome. This will facilitate the identification of biomarkers and potential pathways of muscle-wasting conditions for use in clinics.

摘要

骨骼肌的内稳态对于维持健康和积极的生活方式至关重要。肌肉内稳态失衡会导致严重后果,如萎缩、肌肉质量丧失以及功能逐渐丧失。与年龄相关的肌肉消耗、肌肉减少症以及疾病引起的萎缩(如恶病质)会降低生活质量,增加发病率,并导致整体预后不良。研究与肌肉萎缩疾病相关的肌肉蛋白质组学对于诊断医学具有很大的潜力,可以识别:(i) 潜在的蛋白质生物标志物,以及 (ii) 肌肉消耗、恶病质、肌肉减少症和衰老所共有的或独特的生物学过程和功能。我们对 24 项使用组织样本(骨骼肌和脂肪活检)和/或生物流体(血清、血浆、尿液)的人类蛋白质组学研究进行了基因本体 (GO) 分析的荟萃分析。虽然各研究之间的蛋白质方向性相似之处很少,但确定了与各种情况共同存在的生物学过程。在这里,我们证明了对已发表的人类蛋白质组学数据的 GO 分析可以识别单个研究未揭示的过程。我们建议整合组织样本和生物流体的蛋白质组学数据,以全面了解人类骨骼肌蛋白质组。这将有助于鉴定肌肉消耗疾病的生物标志物和潜在途径,以便在临床上使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/9457532/2a38d73ef9bf/molecules-27-05514-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/9457532/b846148e67b7/molecules-27-05514-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/9457532/3872eb1341bf/molecules-27-05514-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/9457532/cb9074dbc67d/molecules-27-05514-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/9457532/1dfcad92a7a5/molecules-27-05514-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/9457532/c2e86ed367e5/molecules-27-05514-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/9457532/034dff4b16f5/molecules-27-05514-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/9457532/2a38d73ef9bf/molecules-27-05514-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/9457532/b846148e67b7/molecules-27-05514-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/9457532/3872eb1341bf/molecules-27-05514-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/9457532/cb9074dbc67d/molecules-27-05514-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/9457532/1dfcad92a7a5/molecules-27-05514-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/9457532/c2e86ed367e5/molecules-27-05514-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/9457532/034dff4b16f5/molecules-27-05514-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f42/9457532/2a38d73ef9bf/molecules-27-05514-g007.jpg

相似文献

1
Gene Ontology (GO)-Driven Inference of Candidate Proteomic Markers Associated with Muscle Atrophy Conditions.基于基因本体论(GO)的肌肉萎缩相关候选蛋白质标志物的推断。
Molecules. 2022 Aug 27;27(17):5514. doi: 10.3390/molecules27175514.
2
Comprehensive proteome analysis of human skeletal muscle in cachexia and sarcopenia: a pilot study.恶病质和肌肉减少症患者骨骼肌的综合蛋白质组分析:一项初步研究。
J Cachexia Sarcopenia Muscle. 2017 Aug;8(4):567-582. doi: 10.1002/jcsm.12188. Epub 2017 Mar 15.
3
Skeletal muscle loss: cachexia, sarcopenia, and inactivity.骨骼肌丧失:恶病质、少肌症和不活动。
Am J Clin Nutr. 2010 Apr;91(4):1123S-1127S. doi: 10.3945/ajcn.2010.28608A. Epub 2010 Feb 17.
4
Loss of muscle mass: Current developments in cachexia and sarcopenia focused on biomarkers and treatment.肌肉质量的丧失:恶病质和肌肉减少症的当前进展聚焦于生物标志物和治疗。
Int J Cardiol. 2016 Jan 1;202:766-72. doi: 10.1016/j.ijcard.2015.10.033. Epub 2015 Oct 9.
5
Integrated genomic and proteomic analyses identify stimulus-dependent molecular changes associated with distinct modes of skeletal muscle atrophy.整合基因组和蛋白质组分析鉴定了与不同类型骨骼肌萎缩相关的刺激依赖性分子变化。
Cell Rep. 2021 Nov 9;37(6):109971. doi: 10.1016/j.celrep.2021.109971.
6
The role of TGF-β signaling in muscle atrophy, sarcopenia and cancer cachexia.TGF-β 信号通路在肌肉萎缩、少肌症和癌性恶病质中的作用。
Gen Comp Endocrinol. 2024 Jul 1;353:114513. doi: 10.1016/j.ygcen.2024.114513. Epub 2024 Apr 10.
7
Skeletal muscle wasting after a severe burn is a consequence of cachexia and sarcopenia.严重烧伤后骨骼肌减少是恶病质和肌肉减少症的结果。
JPEN J Parenter Enteral Nutr. 2021 Nov;45(8):1627-1633. doi: 10.1002/jpen.2238. Epub 2021 Sep 2.
8
Comparative plasma proteomics in muscle atrophy during cancer-cachexia and disuse: The search for atrokines.癌症恶病质和废用性肌肉萎缩过程中的比较血浆蛋白质组学:萎缩原的寻找。
Physiol Rep. 2020 Oct;8(19):e14608. doi: 10.14814/phy2.14608.
9
Molecular mechanisms and treatment targets of muscle wasting and cachexia in heart failure: an overview.心力衰竭中肌肉减少症和恶病质的分子机制和治疗靶点:概述。
Curr Opin Support Palliat Care. 2014 Mar;8(1):15-24. doi: 10.1097/SPC.0000000000000030.
10
Vitamin D, muscle recovery, sarcopenia, cachexia, and muscle atrophy.维生素 D、肌肉恢复、肌肉减少症、恶病质和肌肉萎缩。
Nutrition. 2019 Apr;60:66-69. doi: 10.1016/j.nut.2018.09.031. Epub 2018 Oct 7.

引用本文的文献

1
Towards Precision in Sarcopenia Assessment: The Challenges of Multimodal Data Analysis in the Era of AI.迈向肌肉减少症评估的精准化:人工智能时代多模态数据分析的挑战
Int J Mol Sci. 2025 May 7;26(9):4428. doi: 10.3390/ijms26094428.
2
Identification of key hub genes in knee osteoarthritis through integrated bioinformatics analysis.通过综合生物信息学分析鉴定膝骨关节炎的关键枢纽基因。
Sci Rep. 2024 Sep 28;14(1):22437. doi: 10.1038/s41598-024-73188-z.
3
Identification of Novel Biomarkers of Spinal Muscular Atrophy and Therapeutic Response by Proteomic and Metabolomic Profiling of Human Biological Fluid Samples.

本文引用的文献

1
Environmental interventions for preventing falls in older people living in the community.环境干预措施预防社区居住老年人跌倒。
Cochrane Database Syst Rev. 2023 Mar 10;3(3):CD013258. doi: 10.1002/14651858.CD013258.pub2.
2
NCAM1 and GDF15 are biomarkers of Charcot-Marie-Tooth disease in patients and mice.神经细胞黏附分子 1 和生长分化因子 15 是患者和小鼠中的夏科-马里-图什病的生物标志物。
Brain. 2022 Nov 21;145(11):3999-4015. doi: 10.1093/brain/awac055.
3
Biomarkers shared by frailty and sarcopenia in older adults: A systematic review and meta-analysis.
通过对人类生物流体样本进行蛋白质组学和代谢组学分析来鉴定脊髓性肌萎缩症的新型生物标志物及治疗反应
Biomedicines. 2023 Apr 23;11(5):1254. doi: 10.3390/biomedicines11051254.
4
Fiber-Type Shifting in Sarcopenia of Old Age: Proteomic Profiling of the Contractile Apparatus of Skeletal Muscles.衰老性肌肉减少症中的纤维类型转变:骨骼肌收缩装置的蛋白质组学分析。
Int J Mol Sci. 2023 Jan 26;24(3):2415. doi: 10.3390/ijms24032415.
老年人虚弱和肌肉减少症的共同生物标志物:系统评价和荟萃分析。
Ageing Res Rev. 2022 Jan;73:101530. doi: 10.1016/j.arr.2021.101530. Epub 2021 Nov 25.
4
Therapeutic Implications of miRNAs for Muscle-Wasting Conditions.miRNAs 治疗肌肉减少症的意义。
Cells. 2021 Nov 5;10(11):3035. doi: 10.3390/cells10113035.
5
Influence of IGF-I serum concentration on muscular regeneration capacity in patients with sarcopenia.IGF-I 血清浓度对肌少症患者肌肉再生能力的影响。
BMC Musculoskelet Disord. 2021 Sep 20;22(1):807. doi: 10.1186/s12891-021-04699-3.
6
Metabolic Remodeling in Skeletal Muscle Atrophy as a Therapeutic Target.骨骼肌萎缩中的代谢重塑作为治疗靶点
Metabolites. 2021 Aug 5;11(8):517. doi: 10.3390/metabo11080517.
7
Adherence to Neuromuscular Electrical Stimulation Interventions for Muscle Impairment in Hip and Knee Osteoarthritis: A Systematic Review.髋膝关节骨关节炎肌肉损伤的神经肌肉电刺激干预依从性:一项系统评价
Clin Med Insights Arthritis Musculoskelet Disord. 2021 Jun 27;14:11795441211028746. doi: 10.1177/11795441211028746. eCollection 2021.
8
Muscle weakness caused by cancer and chemotherapy is associated with loss of motor unit connectivity.癌症和化疗引起的肌肉无力与运动单位连接性丧失有关。
Am J Cancer Res. 2021 Jun 15;11(6):2990-3001. eCollection 2021.
9
A Metabolic Change towards Fermentation Drives Cancer Cachexia in Myotubes.向发酵的代谢变化驱动肌管中的癌症恶病质。
Biomedicines. 2021 Jun 20;9(6):698. doi: 10.3390/biomedicines9060698.
10
Exercise mimetics: harnessing the therapeutic effects of physical activity.运动模拟物:利用身体活动的治疗效果。
Nat Rev Drug Discov. 2021 Nov;20(11):862-879. doi: 10.1038/s41573-021-00217-1. Epub 2021 Jun 8.